Seegene Debuts CURECATM and STAgoraTM at ADLM 2025, Pioneering the Following Leap in Diagnostic Technology
In a groundbreaking move, Seegene Inc. unveiled two new technologies at the ADLM 2025 conference in Chicago: CURECATM and STAgoraTM. These innovative solutions are poised to reshape the diagnostics landscape, offering the world's first fully automated PCR testing system and a powerful data analytics platform [1][2][3].
CURECATM is designed to fully automate every step of PCR testing, including pre-treatment, a traditionally manual process that has been a persistent barrier to automation in diagnostics [1][2]. This full automation, from sample loading through nucleic acid extraction, amplification, and result analysis, is intended to operate continuously 24/7 without any human intervention [2][3][4].
Key innovations enabling this transformation include the CURECATM Prep module, which handles a wide variety of specimen types (urine, blood, sputum, stool), reducing labor demands and expanding sample throughput [1][2]. The system's modular, scalable design allows it to fit different lab sizes and workflows, making it adaptable for diverse laboratory environments and operational needs [1][2].
By automating repetitive, labor-intensive steps, CURECATM allows laboratory personnel to focus on higher-value tasks such as data analysis and clinical interpretation, improving workforce productivity in high-volume labs [2]. Moreover, the system's 24/7 continuous operation enables uninterrupted specimen input and processing, improving turnaround times and enabling sustained high-quality testing [1][2].
Beyond PCR diagnostics, the automation technology of the CURECATM Prep module is envisioned to extend to other areas like clinical chemistry and immunodiagnostics, potentially revolutionizing broader laboratory automation landscapes [1][2].
Complementing CURECATM, Seegene also introduced STAgoraTM, a real-time data analytics platform designed to collect and analyze PCR testing data, providing broader context for diagnostic workflows [2][3][4]. STAgoraTM is built as an integrated platform to help laboratories derive meaningful, aggregated insights from testing data.
STAgoraTM includes over 40 analytical tools, offering functions such as infection trend tracking, hospital-level positivity monitoring, and multi-pathogen co-infection pattern analysis [5]. The data shared through STAgoraTM is de-identified and formatted according to each institution's requirements, supporting secure, real-time exchange at local, national, or global levels [6].
STAgoraTM enables hospitals to build their own statistical datasets and compare aggregated data across institutions, helping them detect infection patterns faster and support more informed decision-making [7].
Industry experts at ADLM 2025 showed strong interest in CURECATM and STAgoraTM. Jamel Giuma, President and CEO of JTG Consulting Group, described CURECATM as one of the most innovative solutions he has seen, with the potential to simplify laboratory workflows, reduce the burden on lab personnel, and enhance operational efficiency [8].
Dr. Chun, CEO of Seegene, reiterated the company's long-term vision of building "a world free from diseases" with the introduction of CURECATM and STAgoraTM, completing the company's five core technology pillars [9]. CURECATM and STAgoraTM, according to Dr. Chun, address long-standing barriers in molecular diagnostics and have the potential to redefine what is possible in diagnostic testing [9].
It's important to note that CURECATM and STAgoraTM demonstrated at ADLM 2025 are pre-commercial technologies under development and are not currently cleared for clinical diagnostic use in any jurisdiction [10].
In summary, Seegene’s CURECATM system revolutionizes molecular diagnostics by fully automating all PCR testing steps, reducing errors, staffing needs, and downtime while increasing throughput and adaptability, thereby improving laboratory efficiency and shaping the future of global diagnostics [1][2][3][4][5]. The data analytics capabilities offered by STAgoraTM further enhance the utility of the diagnostics ecosystem, supporting clinical decision-making and providing epidemiological insights.
- The CURECATM system, a game-changer in the field of science, is poised to streamline medical-conditions diagnostics by automating every step of PCR testing, thereby improving health-and-wellness and reducing lab personnel's workload.
- By introducing STAgoraTM, a powerful data analytics platform, Seegene is advancing technology in the realm of health-and-wellness by offering a platform that collects and analyzes PCR testing data, providing valuable insights for better medical-conditions diagnosis and treatment decisions.
